CCL2 and neoplasm: In our in vivo model, however, properdin-deficient mice, when inoculated with logarithmically growing B16F10 cells, showed decreased levels in blood of the chemoattractants C5a and CCL2 and in tumour of the mediators CCL2, CCL3, IL-13, and TIMP-1.